Literature DB >> 24412346

Mitochondria: mitochondrial OXPHOS (dys) function ex vivo--the use of primary fibroblasts.

Ann Saada1.   

Abstract

Mitochondria are intracellular organelles present in all nucleated cells. They perform a number of vital metabolic processes but their main function is to generate energy in the form of ATP by oxidative phosphorylation (OXPHOS), performed by the mitochondrial respiratory chain. Mitochondrial diseases affecting oxidative phosphorylation are a common group of inherited disorders with variable clinical manifestations. They are caused by mutations either in the mitochondrial or the nuclear genome. In order to study this group of heterogeneous diseases, they are often modeled in animal and microbial systems. However, these are complex, time consuming and unavailable for each specific mutation. Conversely, skin fibroblasts derived from patients provide a feasible alternative. The usefulness of fibroblasts in culture to verify and study the pathomechanism of new mitochondrial diseases and to evaluate the efficacy of individual treatment options is summarized in this review.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fibroblast; Mitochondria; Mitochondrial diseases; Mitochondrial respiratory chain; Oxidative phosphorylation OXPHOS

Mesh:

Year:  2014        PMID: 24412346     DOI: 10.1016/j.biocel.2013.12.010

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  14 in total

Review 1.  Maternally inherited mitochondrial respiratory disorders: from pathogenetic principles to therapeutic implications.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Mol Genet Metab       Date:  2020-06-27       Impact factor: 4.797

Review 2.  Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.

Authors:  Adam J Kuszak; Michael Graham Espey; Marni J Falk; Marissa A Holmbeck; Giovanni Manfredi; Gerald S Shadel; Hilary J Vernon; Zarazuela Zolkipli-Cunningham
Journal:  Annu Rev Pathol       Date:  2017-11-03       Impact factor: 23.472

3.  Revisiting mitochondrial diagnostic criteria in the new era of genomics.

Authors:  Peter Witters; Ann Saada; Tomas Honzik; Marketa Tesarova; Stephanie Kleinle; Rita Horvath; Amy Goldstein; Eva Morava
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.822

4.  Neuronal and astrocyte dysfunction diverges from embryonic fibroblasts in the Ndufs4fky/fky mouse.

Authors:  Matthew J Bird; Xiaonan W Wijeyeratne; Jasper C Komen; Adrienne Laskowski; Michael T Ryan; David R Thorburn; Ann E Frazier
Journal:  Biosci Rep       Date:  2014-11-21       Impact factor: 3.840

5.  Upregulation of Mitochondrial Content in Cytochrome c Oxidase Deficient Fibroblasts.

Authors:  Aviram Kogot-Levin; Ann Saada; Gil Leibowitz; Devorah Soiferman; Liza Douiev; Itamar Raz; Sarah Weksler-Zangen
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

Review 6.  The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy.

Authors:  Yaojie Fu; Shanshan Liu; Shanghelin Yin; Weihong Niu; Wei Xiong; Ming Tan; Guiyuan Li; Ming Zhou
Journal:  Oncotarget       Date:  2017-05-25

7.  Pathological presentation of cardiac mitochondria in a rat model for chronic kidney disease.

Authors:  Einat Bigelman; Lena Cohen; Genya Aharon-Hananel; Ran Levy; Zach Rozenbaum; Ann Saada; Gad Keren; Michal Entin-Meer
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

8.  Novel NDUFA13 Mutations Associated with OXPHOS Deficiency and Leigh Syndrome: A Second Family Report.

Authors:  Adrián González-Quintana; Inés García-Consuegra; Amaya Belanger-Quintana; Pablo Serrano-Lorenzo; Alejandro Lucia; Alberto Blázquez; Jorge Docampo; Cristina Ugalde; María Morán; Joaquín Arenas; Miguel A Martín
Journal:  Genes (Basel)       Date:  2020-07-26       Impact factor: 4.096

9.  Molecular profiling of microinvasive breast cancer microenvironment progression.

Authors:  F Lessi; C Scatena; P Aretini; M Menicagli; S Franceschi; A G Naccarato; C M Mazzanti
Journal:  J Transl Med       Date:  2019-06-03       Impact factor: 5.531

Review 10.  The pursuit of precision mitochondrial medicine: Harnessing preclinical cellular and animal models to optimize mitochondrial disease therapeutic discovery.

Authors:  Marni J Falk
Journal:  J Inherit Metab Dis       Date:  2020-11-02       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.